We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App




Mindray’s BS-600M Chemistry Analyzer with High Sigma Level Boosts Lab Performance

By LabMedica International staff writers
Posted on 18 Jul 2022

The quality of healthcare is a growing concern worldwide. More...

In clinical laboratories, it is essential to define the quality required by an analytical testing process. Sigma metrics are known to be a useful tool for benchmarking the performance of methods. In the six Sigma methodology, “Defects per Million Opportunities (DPMO)” is used as the unit for calculation. A Sigma value indicates the frequency of defects occurring in a process. Therefore, a higher Sigma value translates into a lower number of defects and a lower Sigma value means a higher number of defects. Mindray (Shenzhen, China) has used the Sigma method decision chart to plot the performance of 30 biochemistry parameters on its BS-600M chemistry analyzer. Original reagents and validated application protocol lower the inaccuracy and imprecision which contributes to achieving world-class and excellent Sigma metric performance. Higher Sigma level system can help laboratories offer high level of quality at reduced cost and enhance clinician confidence and satisfaction.

A high Sigma performance means high quality of measurement, which can improve clinicians’ confidence and satisfaction. Besides performance benchmarking, Sigma metrics can also be used by laboratories to design quality control processes. For assays with 6-Sigma performance, the official recommendation is that laboratories can run QC every 1000 patient samples. For those with 3-Sigma performance, it is recommended to run QC every 45 patient samples.

So, what does that mean? How does that impact the laboratory? A high Sigma performance level helps laboratories reduce QC measurements, simplify QC rules, and shorten the TAT. It also contributes to a reduced need for trouble shooting due to false QC violations and less QC and reagent consumption. Therefore, with its high Sigma level, Mindray’s BS-600M system can help laboratories offer high level of quality at reduced costs and boost clinicians’ confidence and laboratories’ reputation.

Related Links:
Mindray 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Graphical Abstract (Image Credit: Cheng N, Ouellette TW, Skead K, et al. Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell Genomics (2026). DOI:10.1016/j.xgen.2026.101364)

Blood Test Stratifies Prostate and Breast Cancer Risk Years Before Diagnosis

Cancer is the second leading cause of death globally, and late diagnosis contributes substantially to mortality. Routine screening is available for only a few cancer types, while other early detection... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.